Page last updated: 2024-09-03

garenoxacin and Gram-Positive Bacterial Infections

garenoxacin has been researched along with Gram-Positive Bacterial Infections in 4 studies

*Gram-Positive Bacterial Infections: Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. [MeSH]

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohen, MA; Ellsworth, E; Gage, JW; Gibson, GW; Gracheck, SJ; Hanna, DL; Huband, MD; Skerlos, LA; Stier, MA; Sulavik, MC; Zurack, M	1
Bello, A; Gajjar, DA; Grasela, DM; Meurling, L; Nord, CE; Russo, RL	1
Jones, RN; Pfaller, MA; Stilwell, M	1
Gordon, KA; Jones, RN; Pfaller, MA	1

Trials

1 trial(s) available for garenoxacin and Gram-Positive Bacterial Infections

Article	Year
Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin. Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:3 Topics: Administration, Oral; Adolescent; Biological Availability; Colony Count, Microbial; Digoxin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Eubacterium; Feces; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Indoles; Intestinal Mucosa; Male; Microbial Sensitivity Tests; Prospective Studies; Quinolones; Sensitivity and Specificity	2003

Article

Year

Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin.

Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:3

Topics: Administration, Oral; Adolescent; Biological Availability; Colony Count, Microbial; Digoxin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Eubacterium; Feces; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Indoles; Intestinal Mucosa; Male; Microbial Sensitivity Tests; Prospective Studies; Quinolones; Sensitivity and Specificity

2003

Other Studies

3 other study(ies) available for garenoxacin and Gram-Positive Bacterial Infections

Article	Year
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Pyrrolidines; Quinazolinones; Topoisomerase II Inhibitors	2007
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci. Diagnostic microbiology and infectious disease, 2001, Volume: 39, Issue:2 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Indoles; Microbial Sensitivity Tests; Quinolones	2001
BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000). The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:5 Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Indoles; Microbial Sensitivity Tests; Population Surveillance; Quinolones	2002